WASHINGTON, DC, April 3, 2024 – Xalles Holdings Inc. (OTC: XALL) proudly announces that its subsidiary, CashXAI Inc. ("CashX"), has integrated the RxSpark prescription and wellness program into the CashX mobile wallet. This strategic move offers affordable prescription options and direct access to live doctors, significantly advancing financial and healthcare accessibility for underbanked communities.
Embedded within the CashX mobile wallet, RxSpark delivers up to 90% savings on prescription medications. This facilitates an easier way for users to manage their healthcare expenses, comparing prices at local pharmacies directly from their mobile devices.
The platform offers substantial discounts, a rewards program, secure prescription management, and access to a broad range of healthcare services, including lab tests and telehealth appointments. With features catering to both English and Spanish speakers, RxSpark stands as a comprehensive solution for enhancing health and wellness management.
Recognizing the need for accessible information in native languages, RxSpark has launched designated websites for CashXRx in both English and Spanish. These platforms serve to accommodate a broader audience, ensuring that users can access information in their preferred language. The English version is available at https://cashxrx.com, and the dedicated Spanish language site can be accessed at https://es.cashxrx.com/, catering to the linguistic needs of all customers.
This integration represents a significant leap forward in combining financial and health wellness for the underbanked. CashX and RxSpark together are addressing vital needs by making healthcare more affordable and accessible while continuing to offer innovative financial services.
Stephen Combe, CEO of CashX, said, "This partnership with RxSpark marks a key advancement in our effort to merge financial and healthcare access for the underbanked, setting a new standard for inclusivity."
John Casson, CEO of RxSpark, stated, "Joining forces with CashX accelerates our mission to reduce healthcare costs. It's a powerful step towards broader, affordable health access for everyone."
About CashXAI Inc.
CashXAI Inc., a leader in financial innovation, provides a dynamic platform for individuals without traditional banking access. The CashX mobile app simplifies the conversion of cash into digital currency, supporting transactions from bill payments to cryptocurrency investments without requiring a bank account. With a vast retail network, CashX offers unparalleled financial freedom and management capabilities, empowering users to control their finances effortlessly from anywhere.
Recent partnerships, including the integration of the RxSpark prescription and wellness program highlight CashXAI's commitment to enhancing financial and healthcare accessibility. These strategic moves not only broaden service offerings but also reinforce CashX's position at the forefront of bridging financial gaps for underbanked communities. For more information, please visit the CashX website at https://cashx.ai/.
About Xalles Holdings Inc. (OTC Pink: XALL)
Xalles Holdings Inc. is a leading holding company, specializing in innovative technology and financial service solutions. Focused on growth and diversification, Xalles Holdings is committed to developing cutting-edge technology-based solutions across various sectors, with an emphasis on supporting disruptive companies. Utilizing its proprietary Xalles RISE Business Model (Roll In, Selected Exit), the company actively seeks acquisition targets with solid management teams, robust business models, expansive total attainable markets (TAM), and enticing exit opportunities. Emphasizing the integration of blockchain and cutting-edge technologies, Xalles provides industry-leading solutions, poised to capture recurring revenue streams over time. Discover more at Xalles.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.
Investor Relations Contact:
IR: 202.779.1460